Impact BioMedical (IBO) vs Lite Strategy (LITS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Impact BioMedical (IBO) has outperformed Lite Strategy (LITS) over the past year, losing 42.7% versus a loss of 48.2%. Lite Strategy is the larger company by market cap ($36.8 million vs $36.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IBO | LITS |
|---|---|---|
| Share price | $4.30 | $1.21 |
| Market cap | $36.74M | $36.79M |
| 1-day change | -4.02% | -4.72% |
| YTD return | -29.92% | -3.79% |
| 1-year return | -42.73% | -48.16% |
| 5-year return | — | -97.82% |
| P/E ratio (TTM) | 0.39 | — |
| EPS (TTM) | $11.11 | $-2.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $10.51 | $2.97 |
| 52-week low | $4.18 | $0.69 |
| Distance from 52-week high | -59.07% | -59.26% |
| Average volume | 11.61K | 448.62K |
| Shares outstanding | 8.54M | 30.41M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
IBO vs LITS FAQ
Which is bigger, Impact BioMedical or Lite Strategy?
Lite Strategy (LITS) is larger, with a market capitalization of $36.79M compared with $36.74M for Impact BioMedical (IBO).
Which stock has performed better over the past year, IBO or LITS?
IBO returned -42.73% over the past 12 months, compared with -48.16% for LITS (price return, excluding dividends). Past performance does not predict future results.
Are Impact BioMedical and Lite Strategy in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.